Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about TEVA PHARMACEUTICAL INDUST
03:54p Drugmakers Amneal, Impax to combine in generics push
02:06p TEVA PHARMACEUTICAL INDUSTRIES : Announces Submission of Biologics License Appli..
10/16 TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
10/14 DEADLINE ALERT : Brower Piven Reminds Shareholders of Approaching Deadline in Cl..
10/12 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2017 Financial Results ..
10/11 Law Offices of Howard G. Smith Announces the Filing of a Securities Class Act..
10/10 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2017 Financial Results ..
10/09 TEVA PHARMACEUTICAL INDUSTRIES : Announces tomy's Award Winner at Oncology Satel..
10/08 CHAIM HURVITZ : Teva can realize $5b in assets
10/07 TEVA PHARMACEUTICAL ClaimsFiler Reminds Investors with Losses in Excess of $1..
10/06 TEVA PHARMACEUTICAL INDUSTRIES : Comments on Anticipated At Risk U.S. Launch of ..
10/05 MYLAN N.V.(NASDAQ : MYL)’s Generic Version Of Teva Pharmaceutical Industri..
10/05 TEVA : Announces tomy’s Award Winner at Oncology Satellite Symposium Durin..
10/04 TEVA PHARMACEUTICAL INDUSTRIES : Big blow for Teva as FDA approves Mylan's gener..
10/04 TEVA PHARMACEUTICAL INDUSTRIES : FDA approves a generic version of Teva Pharmace..
More most relevant news
All news about TEVA PHARMACEUTICAL INDUST
04:22p TEVA PHARMACEUTICAL INDUSTRIES LIMIT : TEVA The Law Offices of Vincent Wong Remi..
04:15p TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
03:54p Drugmakers Amneal, Impax to combine in generics push
02:06p TEVA PHARMACEUTICAL INDUSTRIES : Announces Submission of Biologics License Appli..
10/16 TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Khang & Khang LLP Announces Securities Cl..
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Levi & Korsinsky, LLP Reminds Shareholder..
10/14 DEADLINE ALERT : Brower Piven Reminds Shareholders of Approaching Deadline in Cl..
10/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : SHAREHOLDER REMINDER: Lundin Law PC Annou..
10/13 Antares Pharma Provides XYOSTED Regulatory Update
More news
Sector news : Pharmaceuticals - NEC
03:54p Drugmakers Amneal, Impax to combine in generics push
11:09aDJHUTCHISON CHINA MEDITECH : AstraZeneca Say Drug Shows Potential to Treat Lung Ca..
08:48aDJDaimler Charts Leaner Approach -- WSJ
08:46aDJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
06:48aDJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
10/16DJALLERGAN : Loses Patent Fight in Federal Court
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09:59a Teva submits U.S. marketing application for migraine med fremanezumab
10/16 TEVA'S ONGOING COMPLICATIONS : Psychology And Generic Drugs
10/16 U.S. court invalidates Allergan's Restasis patents; shares down 5%
10/16 SANOFI : Upward Trajectory In 2017
10/16 Mylan Calls Allergan's Mohawk Deal A 'Sham'
10/16 TEVA : The Market Underreacted On Copaxone News, But The Stock Is Just So Cheap
Latest Tweets
10/15Gofen & Glossberg LLC IL Has $2.25 Million Holdings in Teva Pharmaceutica.. 
10/15Teva Pharmaceutical Industries Limited $TEVA Stock Rating Lowered by BidaskCl.. 
10/14Teva Pharmaceutical Industries Limited downgraded by BidaskClub to strong sel.. 
10/11INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsu.. 
10/10Teva Pharmaceutical Industries : to Report Third Quarter 2017 Financial Resul.. 
More tweets
Qtime:166
Financials ($)
Sales 2017 22 644 M
EBIT 2017 6 282 M
Net income 2017 -
Debt 2017 34 451 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 2,19x
EV / Sales 2018 2,08x
Capitalization 15 186 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 28,0 $
Spread / Average Target 87%
Managers
NameTitle
Kåre Schultz President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-59.72%15 186
JOHNSON & JOHNSON18.42%365 346
NOVARTIS13.23%226 956
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751